Biotech valuations and investing peaked in late 2021, with investors surging into the sector at the height of the Covid-19 pandemic. Interest in the sector waned over the last few years — due in part to sharply increased interest rates and the rapid emergence of the AI mega trend. But now, the smart money is starting to flow back into the
sector…
Millions of Americans trusted them. Yet even the worst health crisis in over a century … couldn’t keep them from feathering their nest.
Big Tech stocks have bounced back in recent weeks, thanks in part to signs that inflation might be slowing. If so, the Federal Reserve’s aggressive rate hikes would be near their end — but I’m not so sure. Today I’ll show you why inflation is nowhere near over, and why the Fed’s weapons to fight it off are weaker than they’ve ever been before.
(2-minute read) While most investors are hiding under their beds, Charles has been finding pockets of opportunities. Find out what they are…
(4-minute read) Every market downturn looks like the big one that’ll destroy the economy. Charles share’s why that’s not the case…
Director of VIP Services
Research Analyst
Editor of Strategic Fortunes and three elite services
Chief Investment Strategist of Money & Markets
Editor of Alpha Investor